IRIDEX Corp. (IRIX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156229,
    "name": "IRIDEX Corp.",
    "stock_name": "IRIDEX Corp.",
    "full_name": "IRIDEX Corp.",
    "name_url": "stocks-analysis/iridex-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.93",
    "chg": 0.01,
    "chgp": "0.67%",
    "dir": 1,
    "prev_price": "0.92",
    "mcapval": "23.45",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US4626841013",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "80.1 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/iridex-corp-1156229-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is IRIDEX Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iridex-corp-technically-bullish-or-bearish-3545429",
        "imagepath": "",
        "date": "2025-09-20 19:11:40",
        "description": "As of 10 July 2025, the technical trend for IRIDEX Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while weekly MACD and KST show bullish signals. However, the monthly indicators for Bollinger Bands and KST are bearish, contributing to the overall mildly bearish outlook. The RSI shows no signals in both weekly and monthly time frames. There is no available return data to compare the company's performance against the S&P 500...."
      },
      {
        "title": "Is IRIDEX Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-iridex-corp-overvalued-or-undervalued-3542136",
        "imagepath": "",
        "date": "2025-09-20 17:45:43",
        "description": "As of 3 November 2016, the valuation grade for IRIDEX Corp. moved from expensive to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued based on its current financial metrics. Key ratios include a Price to Book Value of 16.34, an EV to EBIT of -3.81, and an EV to EBITDA of -5.21, all of which suggest significant challenges in profitability and valuation.\n\nIn comparison to its peers, IRIDEX Corp. has a notably negative EV to EBITDA ratio of -10.2048, while Kewaunee Scientific Corp. stands out with a more favorable P/E of 13.9568. Other risky peers like iCAD, Inc. and Sensus Healthcare, Inc. also reflect poor valuation metrics, further highlighting IRIDEX's struggles within its industry. Although specific return data is not available, the lack of positive performance against the S&P 500 reinforces the notion of the company's overvaluation amidst its financial diffi..."
      }
    ],
    "total": 7,
    "sid": "1156229",
    "stock_news_url": "https://www.marketsmojo.com/news/iridex-corp-1156229"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is IRIDEX Corp. technically bullish or bearish?

2025-09-20 19:11:40

As of 10 July 2025, the technical trend for IRIDEX Corp. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by daily moving averages indicating a bearish trend, while weekly MACD and KST show bullish signals. However, the monthly indicators for Bollinger Bands and KST are bearish, contributing to the overall mildly bearish outlook. The RSI shows no signals in both weekly and monthly time frames. There is no available return data to compare the company's performance against the S&P 500....

Is IRIDEX Corp. overvalued or undervalued?

2025-09-20 17:45:43

As of 3 November 2016, the valuation grade for IRIDEX Corp. moved from expensive to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued based on its current financial metrics. Key ratios include a Price to Book Value of 16.34, an EV to EBIT of -3.81, and an EV to EBITDA of -5.21, all of which suggest significant challenges in profitability and valuation. In comparison to its peers, IRIDEX Corp. has a notably negative EV to EBITDA ratio of -10.2048, while Kewaunee Scientific Corp. stands out with a more favorable P/E of 13.9568. Other risky peers like iCAD, Inc. and Sensus Healthcare, Inc. also reflect poor valuation metrics, further highlighting IRIDEX's struggles within its industry. Although specific return data is not available, the lack of positive performance against the S&P 500 reinforces the notion of the company's overvaluation amidst its financial diffi...

View All News